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Abstract
 
Autoimmune gastritis and 
 
Helicobacter pylori
 
–associated gastric atrophy develop through similar
mechanisms involving the proton pump H
 

 
,K
 

 
–adenosine triphosphatase as autoantigen.
Here, we report that 
 
H. pylori
 
–infected patients with gastric autoimmunity harbor in vivo–
activated gastric CD4
 

 
 T cells that recognize both H
 

 
,K
 

 
–adenosine triphosphatase and 
 
H.
pylori
 
 antigens. We characterized the submolecular specificity of such gastric T cells and identi-
 
fied cross-reactive epitopes from nine 
 
H. pylori
 
 proteins. Cross-reactive 
 
H. pylori
 
 peptides induced
T cell proliferation and expression of T helper type 1 functions. We suggest that in genetically
susceptible individuals, 
 
H. pylori
 
 infection can activate cross-reactive gastric T cells leading to
gastric autoimmunity via molecular mimicry.
Key words:
 
Helicobacter pylori
 
 • T cell epitopes • autoreactive T cells • mimicry • 
mucosal immunity
 
Introduction
 
Several mechanisms have been proposed for how pathogens
 
might induce activation and critical expansion of autoreactive
T cells and start autoimmune disease (1–6). Activation of
resting autoreactive T cells may be achieved by viral and
bacterial superantigens that bind a variety of MHC class II
molecules and activate large numbers of T cells, irrespective
of their specificity (7). Pathogen-induced tissue inflamma-
tion may result in local activation of APCs and enhanced
processing/presentation of self antigens that causes T cell
priming, followed by T cell activation and expansion of
additional specificities (epitope spreading; references 8, 9).
Another mechanism would imply that the inflammatory
setting and the paracrine secretion of T cell growth factors
induce the expansion of activated autoreactive T cells,
whose small number was previously insufficient to drive an
autoimmune disease. Such a mechanism is referred to as
bystander activation (10). Moreover, a microbial antigen
can include an epitope that is structurally similar to an
autoantigen epitope, providing the basic element of the
mechanism referred to as molecular mimicry (5, 6, 11–14).
Autoimmune chronic gastritis (AIG) is an organ-specific
inflammatory disease leading to gastric atrophy, hypochlo-
ridria, and eventually to pernicious anemia. AIG is charac-
terized by lymphocytic infiltrates in the gastric mucosa and
by destruction of parietal cells, resulting in mucosal atrophy
(15). In most AIG patients, serum anti-parietal cell autoanti-
bodies (PCAs) are detectable. The autoantigen recognized
is the gastric H
 

 
,K
 

 
–adenosine triphosphatase (ATPase),
the proton pump, localized in the parietal cell canaliculi
(16, 17). H
 

 
,K
 

 
-ATPase is also the target of autoreactive T
cells that infiltrate the gastric mucosa of AIG patients (18).
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Helicobacter pylori
 
 infection is one of the most common
bacterial infections in humans and its clinical outcomes are
highly variable, including chronic gastritis, duodenal or
gastric ulcers, mucosal atrophy, gastric carcinoma, or gastric
lymphoma (19). In 
 
H. pylori
 
–infected patients who develop
gastric corpus atrophy, an increased incidence of positive
PCAs has been reported, which significantly decreases after
 
H. pylori
 
 eradication (20, 21). Based on the similarities be-
tween 
 
H. pylori
 
–induced corpus atrophy and classical AIG,
we inferred that in some individuals genetically predisposed
to organ-specific autoimmunity due to their MHC class II
haplotype, 
 
H. pylori
 
 infection plays a role in induction or
exacerbation of gastric autoimmunity (20).
To test this hypothesis, we selected four women with
chronic AIG and current 
 
H. pylori
 
 infection. Biopsy speci-
mens of their gastric mucosa were cultured in IL-2–condi-
tioned medium to expand in vivo–activated gastric T cells.
Specimens were disrupted, and single T cell blasts were
cloned (18). Gastric T cell clones were screened for their
ability to proliferate in response to H
 

 
,K
 

 
-ATPase and/or
to a 
 
H. pylori
 
 lysate. In addition to CD4
 

 
 T cell clones that
proliferated to 
 
H. pylori
 
 lysate or to H
 

 
,K
 

 
-ATPase, we
found a remarkable number of gastric T cell clones that
recognized both H
 

 
,K
 

 
-ATPase and 
 
H. pylori
 
 antigens,
and we identified their cross-reactive epitopes at the mo-
lecular level.
 
Materials and Methods
 
Generation of Gastric T Cell Clones. 
 
Four women (mean age,
45; range, 29–53 yr) with chronic AIG and thyroiditis provided
their informed consent for this work. Their MHC haplotypes
were as follows: HLA-A2, A11, B35, B41, DRB1
 
*
 
0701, and
DRB1
 
*
 
1303 in patient 1; HLA-A1, A24, B15, B35,
DRB1
 
*
 
0404, and DRB1
 
*
 
0803 in patient 2; HLA-A23, A32,
B27, B35, DRB1
 
*
 
0403, and DRB1
 
*
 
1303 in patient 3; and
HLA-A2, A3, B18, B50, DRB1
 
*
 
0301, and DRB1
 
*
 
1104 in
patient 4. All patients had serum PCAs and thyroid peroxidase
autoantibodies, but not intrinsic factor autoantibodies or
hematologic abnormalities. All the patients were receiving
levothyroxine for hypothyroidism. Patient 4 also suffered from
vitiligo. At the beginning of this work, all patients had positive
serology for 
 
H. pylori
 
 infection, positive [
 
13
 
C]urea breath test,
and positive histology for 
 
H. pylori
 
 at gastroscopy. None of the
patients had 
 
H. pylori
 
 eradication. At the end of a 4-yr follow-
up, in all patients, the [
 
13
 
C]urea breath test was found consis-
tently negative.
Biopsy specimens of gastric mucosa were cultured for 7 d in
RPMI 1640 medium supplemented with 50 U/ml of human IL-2
to expand in vivo–activated T cells. Specimens were disrupted,
and single T cell blasts were cloned (18). In brief, T cell blasts
were seeded under limiting dilution conditions (0.3 cells/well) in
round-bottomed microwells containing 6,000 rad 10
 
5
 
 irradiated
autologous mononuclear cells (as feeder cells) and 1% vol/vol
PHA in a final volume of 0.2 ml of complete medium supple-
mented with 20 U/ml IL-2, 5% human serum, and 10% FCS.
Growing microcultures were supplemented, at weekly intervals,
with 20 U/ml IL-2 and 10
 
5
 
 irradiated feeder cells. Clones were
screened for responsiveness to medium, 5 
 

 
g/ml of porcine albu-
min, 0.5 
 

 
g/ml of porcine gastric H
 

 
,K
 

 
-ATPase (22, 23), and
 
H. pylori
 
 lysate (10 
 

 
g/ml aqueous extract of NCTC11637 strain)
by measuring [
 
3
 
H]TdR uptake after 60 h (18).
 
Analysis of TCR V
 

 
 Chain Repertoire of Gastric T Cell Clones.
 
The repertoire of the TCR V
 

 
 chain of H
 

 
,K
 

 
-ATPase–spe-
cific Th clones was analyzed with a panel of 22 mAbs specific to
the following: V
 

 
1, V
 

 
2, V
 

 
4, V
 

 
7, V
 

 
9, V
 

 
11, V
 

 
14,
V
 

 
16, V
 

 
18, V
 

 
20, V
 

 
21.3, V
 

 
22, and V
 

 
23 (Beckman
Coulter); and V
 

 
3.1, V
 

 
5.1, V
 

 
5.2, V
 

 
5.3, V
 

 
6.7, V
 

 
8,
V
 

 
12, V
 

 
13, and V
 

 
17 (AMS Biotechnology GmbH). Iso-
type-matched nonspecific Ig were used as negative control.
Data acquisition was performed in a FACSCalibur™ flow cy-
tometer using the CELLQuest™ software program (Becton
Dickinson). From each T cell clone, mRNA was extracted by
mRNA direct isolation kit (QIAGEN). For cDNA synthesis,
the same amount of mRNA (50 ng) was used, and cDNA was
synthesized by Moloney murine leukemia virus-reverse tran-
scriptase (New England Biolabs, Inc.) and oligo-(dT) primers
according to the manufacturer’s protocol. cDNA mix of all
samples was amplified under equal conditions by a 30-cycle
PCR using V
 

 
 T cell receptor typing amplimer kit for V
 

 
10,
V
 

 
15, and V
 

 
19 (CLONTECH Laboratories, Inc.) according
to the manufacturer’s instructions.
 
Generation of H
 

 
,K
 

 
-ATPase Overlapping Peptides and Prediction
of Candidate Cross-reactive H. pylori Peptides. 
 
To span the 1,034–
amino acid 
 

 
 chain and the 270–amino acid 
 
 chain of porcine
H,K-ATPase, 205 and 56 overlapping 15-mer peptides with a
10–amino acid overlap, respectively, were prepared by automated
simultaneous multiple peptide synthesis, as described previously
(24). Amino acid sequences of H,K-ATPase epitopes recog-
nized by the 13 cross-reactive T cell clones were used in silico to
identify H. pylori peptides that might be candidates for cross-reac-
tivity. Homologies between the 13 H,K-ATPase epitopes and
peptides present in both genomes of H. pylori J99 and 26695
strains were screened by using the basic local alignment search
tool (BLAST) server of the National Center for Biotechnology
Information. Standard BLAST search parameters were used with
the following adaptations: word size, 2; Expect 100000; Matrix,
Blosum 45 with existence 19 and extension 1 penalty settings.
Amino acid sequences in H. pylori J99 and 26695 open reading
frames (ORFs) with sufficient homology (top 100 of the BLAST
results) to the relevant H,K-ATPase epitopes and with a mini-
mal length of nine amino acids were studied for the presence of
motifs that would predict binding to patient MHC class II alleles
by using the ProPred MHC class II Binding Peptide Prediction
Server (25). The threshold of prediction was set at 3%. Identified
H. pylori peptides were adjusted to a 15–amino acid length based
on the appropriate H. pylori ORFs.
Submolecular Specificity of Gastric T Cell Clones Reactive to
H,K-ATPase or to Both H,K-ATPase and H. pylori Lysate.
Equal amounts of each of the 261 overlapping peptides of
H,K-ATPase were pooled to have 20 pools. 4  104 T cell
blasts from each clone were cultured in triplicate for 3 d together
with 1.5  105 irradiated autologous mononuclear cells in the
presence of medium, 5 g/ml of porcine albumin, 0.5 g/ml
H,K-ATPase, 10 g/ml H. pylori lysate or equal aliquots from
each of the 20 pools in which each peptide component was
present at a 10 g/ml final concentration. After 60 h, [3H]TdR
uptake was measured. Mitogenic index (MI) was calculated as the
ratio between counts in stimulated cultures and those in unstimu-
lated cultures. Each clone was retested for proliferation to the in-
dividual peptide components of the pool that had induced a
MI  5. Finally, each clone was tested for proliferation to H,K-
ATPase, H. pylori lysate, and the appropriate H,K-ATPase
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peptide (as positive controls); the couple of flanking H,K-ATP-
ase peptides (negative controls) and the series of H. pylori peptides
were identified as possible candidates for cross-reactivity to the
appropriate H,K-ATPase epitope.
In some experiments, the effect of 5 g/ml anti–HLA-DR
(clone G46–6) or anti–HLA-DQ (clone TU169; BD Biosciences)
monoclonal antibodies or their isotype control (mouse IgG2a) on
T cell clone proliferation induced by the appropriate H,K-ATP-
ase and H. pylori cross-reactive peptides was assessed.
Cytokine Production Induced by Peptides. T cell blasts of each
cross-reactive clone (5  105) were cocultured in triplicate tubes
for 48 h in 0.5 ml medium with 5  105 irradiated autologous
APCs in the presence of medium, 0.5 g/ml H,K-ATPase, 10
g/ml H. pylori lysate, the appropriate H,K-ATPase peptide,
and the H. pylori cross-reactive peptide that induced proliferation
(10 g/ml), as well as control peptides that failed to induce pro-
liferation. Duplicate samples of each supernatant were assayed for
IL-4, IL-5, and IFN- content by ELISA assays (18).
Perforin-mediated Cytolytic Activity and Fas–Fas Ligand-mediated
Apoptotic Killing. The ability of T cell clones to express per-
forin-mediated cytotoxicity was assessed in a lectin-dependent as-
say against 51Cr-labeled P815 murine mastocytoma cells as de-
scribed previously (26).
The ability of gastric T cell clones to induce Fas–Fas ligand-
mediated apoptosis was assessed using Fas Jurkat cells as target
and the anti-Fas antagonistic mAb M3 (Immunex), as described
previously (18, 27).
Results
Submolecular Specificity of Gastric T Cell Clones Reactive to
H,K-ATPase. A total of 154 CD4 and 49 CD8 T
cell clones were obtained from the gastric biopsies of four
H. pylori–infected AIG patients. All gastric clones were
screened for proliferation to H. pylori lysate, H,K-
ATPase, or porcine albumin (control antigen). No prolif-
eration was detected in any of the CD8 clones and in 108
CD4 T cell clones, although they all proliferated to IL-2.
In contrast, 18 CD4 gastric clones (donor 1, five; donor
2, two; donor 3, four; and donor 4, seven) showed signifi-
cant proliferation (MI range, 38–212) to H. pylori lysate,
but not to H,K-ATPase or porcine albumin, and 15
CD4 clones (donor 1, three; donor 2, five; donor 3, two;
and donor 4, five) proliferated to H,K-ATPase (MI
range, 28–179), but not to H. pylori lysate or porcine al-
bumin. Interestingly, a third group of 13 CD4 clones
was found that proliferated almost equally well to both
H,K-ATPase and H. pylori lysate, but not to porcine al-
bumin (Fig. 1).
T cell blasts from each of the 28 H,K-ATPase–reac-
tive T cell clones were screened for proliferation in re-
sponse to 205 overlapping peptides for the  chain and 56
peptides for the  chain of H,K-ATPase (Table I). In
the series of 15 H,K-ATPase–specific clones that failed
to proliferate to H. pylori lysate, 6 clones recognized an
epitope in the  chain and 9 clones found their epitope in
the  chain of the proton pump. Interestingly, the 881–
895 epitope was recognized by a couple of clones from do-
nor 2 (2.P02 and 2.P14), in spite of their different expres-
sion of TCR-V. Likewise, different TCR-V regions
were expressed by the two clones from donor 3 and the
three clones from donor 4 that recognized the same
epitopes (231-245 and 76-90, respectively).
In the series of 13 clones that proliferated to both
H,K-ATPase and H. pylori lysate, 11 recognized their
epitope in the  chain and 2 clones in the  chain. Two
clones from different patients (2.R37 and 3.A30, bearing
different TCR-V) recognized the same 836-850 epitope,
and two other clones in this series (1.C31 and 4.A05) recog-
nized the same 621-635 epitope. No overlap was found
between the H,K-ATPase epitopes recognized by clones
reactive only to H,K-ATPase and the H,K-ATPase
epitopes recognized by clones able to proliferate to both
H,K-ATPase and H. pylori lysate (Table I).
Evidence for clonality of the cross-reactive CD4 T cell
clones was provided by the unique products of PCR analy-
sis of TCR-V mRNA expression in clones 1.A12 (V19)
and 2.R37 (V15; unpublished data) or by the cytofluori-
metric patterns of single TCR-V expression shown by
Figure 1. Proliferation to H,K-ATPase and H. pylori of gastric T cell
clones. T cell blasts from 13 CD4 clones derived from the gastric mucosa
of H. pylori–infected patients with chronic autoimmune gastritis (four
from patient 1, two from patient 2, one from patient 3, and six from patient
4) were cocultured with autologous irradiated APCs in the presence of
optimal concentrations of H,K-ATPase, H. pylori lysate, or porcine
albumin as control antigen. Results represent mean values (	SD) of MIs
measured in five consecutive experiments.
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those clones. Each T cell clone was stained by only one of
the TCR-V chain–specific monoclonal antibodies, show-
ing a single peak of fluorescence intensity (Fig. 2).
Screening for Cross-reactive H. pylori Peptides with Homology
to H,K-ATPase Epitopes. Homologies between the 13
H,K-ATPase epitopes and peptides present in both ge-
nomes of H. pylori J99 and 26695 strains were screened by
using a bioinformatic method. For clone 1.A12 reactive to
the 576-590 epitope and clone 4.C133 reactive to 11-
25, no cross-reactive candidate was predicted in H. pylori
J99 or hp26695 ORFs. For clone 1.C27 that proliferated to
the 216-230 H,K-ATPase epitope, the six predicted H.
pylori peptides were synthesized, but none of them induced
significant proliferation (MI  5). It is of note that the
H,K-ATPase epitopes recognized by the other 10 gastric
clones reactive to both H,K-ATPase and H. pylori lysate
were 100% identical in the pig and human molecules. For
each of these 10 gastric clones, a cross-reactive peptide was
found in the series (n = 73) of candidate H. pylori peptides
we had synthesized (Table II). The two clones from differ-
ent patients (2.R37 and 3.A30), that shared recognition of
the 836–850 H,K-ATPase epitope, also shared the
cross-reactive recognition of the 11-25 sequence of a li-
popolysaccharide biosynthesis protein of H. pylori. The rela-
tive potency in inducing T cell clone proliferation of the self
and of the corresponding microbial peptides was assessed by
comparison of dose–response curves. At 10 nM, self- and
cross-reactive peptides were almost equally potent in induc-
ing T cell clone proliferation. At lower doses (such as 1 or
0.1 nM), the MI obtained with the appropriate self peptides
Table I. Epitope Specificity of Gastric T Cell Clones from H. pylori–infected AIG Patients
T cell clones reactive to H,K-ATPase T cell clones reactive to both H,K-ATPase and H. pylori lysate
Patient H,K-ATPase epitope recognized Mean MI 	 SD H,K-ATPase epitope recognized Mean MI 	 SD
1 C11 (V5.3) 31-45 65 	 9 A12 (V19) 576-590 64 	 10
A01 (V6.7) 81-95 21 	 2 C31 (V13) 621-635 79 	 9
C26 (V13) 166-180 22 	 2 A04 (V13) 781-795 194 	 16
C27 (V13) 216-230 57 	 12
2 Q08 (V4) 1-15 22 	 1 P24 (V4) 46-60 23 	 3
P34 (V19) 151-165 134 	 11 R37 (V15) 836-850 50 	 7
P02 (V8) 881-895 23 	 2
P14 (V19) 881-895 21 	 2
R17 (V4) 111-125 29 	 4
3 A42 (V8) 231-245 122 	 36 A30 (V13) 836-850 49 	 6
B46 (V17) 231-245 68 	 19
4 C39 (V9) 351-365 53 	 4 A15 (V18) 181-195 39 	 2
A09 (V23) 76-90 97 	 12 C32 (V16) 241-255 87 	 9
A33 (V6.7) 76-90 108 	 21 C27 (V5.2) 256-270 137 	 17
C15 (V22) 76-90 72 	 13 C26 (V21.3) 516-530 104 	 9
C03 (V16) 81-95 113 	 19 A05 (V16) 621-635 99 	 12
C13 (V14) 11-25 91 	 14
Figure 2. TCR V chain repertoire of cross-reactive gastric T cell
clones. The clonality of T cell clones reactive to both H,K-ATPase and
H. pylori lysate was analyzed by a panel of 22 monoclonal antibodies specific
for human TCR V chain families, as detailed in Materials and Methods. T
cell blasts from each clone were divided in aliquots and stained with each of
the monoclonal antibody and the appropriate isotype controls.
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was consistently higher (1.4–2-fold) than that obtained with
the corresponding microbial peptides (Fig. 3). However, at
concentrations as low as 1 pM, both self- and cross-reactive
microbial peptides were still stimulatory. To know the
MHC restriction elements required for recognition of self-
or cross-reactive epitopes, T cell clones were stimulated by
the appropriate H,K-ATPase and H. pylori cross-reactive
peptides in the presence of irradiated autologous APCs
treated with anti–HLA-DR or anti–HLA-DQ monoclonal
antibodies. Addition in culture of anti–HLA-DR consis-
tently resulted in virtual abrogation of the proliferative re-
sponse by T cell clones, whereas anti–HLA-DQ was unable
to affect peptide-induced proliferation (Table III).
Cytokine Production Induced by H,K-ATPase and H.
pylori Cross-reactive Peptides. Mapping of the H,K-ATP-
ase peptide specificity and the cross-reactive recognition of
H. pylori peptides based on proliferative response was accom-
plished with the assessment of IFN-, IL-4, and IL-5 pro-
duction induced by the relevant peptides. Upon appropriate
stimulation, all gastric clones produced IFN-, but neither
IL-4 nor IL-5, thus showing a Th1 profile (Fig. 4). In con-
trast, either H,K-ATPase peptides or H. pylori cross-reac-
tive peptides that failed to induce proliferation also failed to
induce cytokine production. From these data, we concluded
that the appropriate H. pylori cross-reactive peptides are as
powerful as the specific H,K-ATPase peptides in inducing
a number of gastric T cells to proliferate and to express their
Th1 functional profile. All gastric clones reactive to both
H,K-ATPase and H. pylori lysate expressed effector func-
tions typical of Th1 cells, such as perforin-mediated cytotox-
icity (range of specific 51Cr release, 36–67%) and Fas–Fas
ligand-mediated proapoptotic activity (range of specific 51Cr
release, 29–51%), which was substantially inhibited (range
37–69%) by an anti-Fas antagonistic antibody. Likewise, gas-
tric clones reactive only to H,K-ATPase were able to ex-
press both perforin-mediated cytotoxicity (range of specific
51Cr release, 24–72%) and proapoptotic activity in the same
target cells (range of specific 51Cr release, 22–59%).
Discussion
The presence in H. pylori–infected AIG patients of gastric
T cells reactive to H. pylori antigens is in agreement with
Figure 3. Dose–response effect of graded concentrations of the self
(closed symbols) and the corresponding bacterial peptides (open symbols)
on the proliferative response of gastric T cell clones reactive to both
H,K-ATPase and H. pylori lysate. Results represent mean values 	 SD
of 6 representative out of 10 T cell clones tested.
Figure 4. IFN- production by cross-reactive gastric
T cell clones. Cytokine production was assessed in
response to H. pylori lysate, H,K-ATPase, the
H,K-ATPase epitope and the cross-reactive H. pylori
epitope that induced T cell clone proliferation. For
each clone, controls included medium alone, a couple
of H,K-ATPase peptides flanking the stimulatory
epitope and the series of candidate H. pylori epitopes
that failed to induce T cell clone proliferation. Numbers
in parentheses indicate the location of cross-reactive
epitopes within the indicated H. pylori proteins. Results
represent mean values 	 SD of 4 representative out of
10 T cell clones tested.
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earlier demonstration of H. pylori–specific T cells in the gas-
tric mucosa of H. pylori–infected individuals without AIG
(28). Likewise, the detection of H,K-ATPase-specific T
cells in the gastric mucosa of AIG patients confirms previous
observation in H. pylori noninfected patients with AIG (18).
The important point of the present paper is the demonstra-
tion that all four H. pylori–infected AIG patients harbored in
their gastric mucosa in vivo–activated T cells that reacted to
both H,K-ATPase and H. pylori. The analysis of the sub-
molecular specificity of T cell clones reactive only to
H,K-ATPase and of clones reactive to both H,K-
ATPase and H. pylori showed that most of the former (9 out
of 15) recognized their epitope in the  chain of the en-
zyme, whereas most of the latter (11 out of 13) found their
epitope in the  chain of H,K-ATPase. Therefore, a
number of H,K-ATPase epitopes are “private,” whereas
other epitopes, mainly in the  chain, are similar to, or
cross-reactive with, epitopes of H. pylori antigens.
For each of 10 cross-reactive gastric clones, bioinformat-
ics provided us with a cross-reactive H. pylori epitope able
to induce significant T cell clone proliferation. Clones R37
from patient 2 and clone A30 from patient 3, which shared
recognition of the 836–850 H,K-ATPase epitope, also
shared cross-reactivity with the 11-25 peptide of a li-
popolysaccharide biosynthesis protein of H. pylori. In con-
trast, for clone C31 from patient 1 and clone A05 from pa-
tient 4, both reactive to 621–635 H,K-ATPase, the
bioinformatic method had predicted two different series of
11 and 8 cross-reactive candidates, respectively. Indeed,
clone 1.C31 reacted quite well only to the 264-278 peptide
of histidine kinase, whereas clone 4.A05 showed cross-rec-
ognition of the 35-49 epitope of porphobilinogen deami-
nase of H. pylori. In summary, our search led to the identi-
fication of nine H. pylori proteins, each harboring a T cell
epitope suitable for cross-reaction with T cell epitopes of
gastric H,K-ATPase  chain.
T cell recognition of cross-reactive H. pylori epitopes re-
sulted in both proliferation and expression of functional
properties by cross-reactive T cell clones. In all clones, the
Th1 cytokine profile expressed upon stimulation with
Table II. Cross-reactive H,K-ATPase and H. pylori Peptides Recognized by Gastric T Cell Clones
T cell clones
(epitope)
Amino acid sequence recognized
H. pylori protein including the
cross-reactive peptide (position)H,K-ATPase bacterial peptide MI 	 SD
1.C31 (621-635) IRVIMVTGDHPITAK 79 	 9
VRVDVRRLDHLMNLI 66 	 5 Histidine kinase (264-278)
1.A04 (781-795) NLKKSIAYTLTKNIP 194 	 16
ISNLPYYIATRLVLN 108 	 12 Dimethyl adenosine transferase (99-113)
2.P24 (46-60) KKEMEINDHQLSVAE 23 	 3
LNNYQKENSLYNHNL 27 	 2 Penicillin-binding protein 2 (104-118)
2.R37 (836-850) KAESDIMHLRPRNPK 50 	 7
NMRVFIIHLSPKTCK 19 	 2 LPS biosynthesis protein (11-25)
3.A30 (836-850) KAESDIMHLRPRNPK 49 	 6
NMRVFIIHLSPKTCK 16 	 1 LPS biosynthesis protein (11-25)
4.A15 (181-195) VIRDGDKFQINADQL 39 	 2
VVQGGDKFHAPVLVD 20 	 1 Acetate kinase (93-107)
4.C32 (241-255) CTHESPLETRNIAFF 87 	 9
VIQIGPMPTPAIAFL 75 	 8 Phosphoglucosamine mutase (70-84)
4.C27 (256-270) STMCLEGTAQGLVVN 137 	 17
ALDSLEKVVARLVVK 34 	 2 VirB4 homologue (78-92)
4.C26 (516-530) VMKGAPERVLERCSS 104 	 9
VFKGIPGLSLEAVEK 47 	 4 GidA (571-585)
4.A05 (621-635) IRVIMVTGDHPITAK 99 	 12
IRIVKTTGDKILDAP 51 	 6 Porphobilinogen deaminase (35-49)
For each gastric T cell clone reactive to both H,K-ATPase and H. pylori, a single H. pylori cross-reactive peptide was identified. Identical amino
acid residues in the recognized H,K-ATPase peptide and the cross-reactive H. pylori peptide are in boldface. H. pylori proteins containing a cross-
reactive epitope recognized by one of the T cell clones in this study are as follows: histidine kinase [HP0392]; dimethyl adenosine transferase
[HP1431]; penicillin-binding protein 2 [HP1565]; LPS (lipopolysaccharide) biosynthesis protein [HP0805]; acetate kinase [HP0903];
phosphoglucosamine mutase [HP0075]; VirB4 homologue [HP0017]; GidA, glucose-inhibited division protein A [HP0213]; and porphobilinogen
deaminase [HP0237]. Codes in brackets indicate the annotated gene number of H. pylori 26695. 
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cross-reactive H. pylori peptides paralleled that disclosed by
stimulation with either bacterial lysate or entire H,K-
ATPase or the appropriate H,K-ATPase epitopes. These
data suggest that cross-reactive H. pylori peptides represent
signals powerful enough to activate the functional program
of gastric cross-reactive Th1 cells. Upon mitogen stimula-
tion, all cross-reactive gastric clones expressed both per-
forin-mediated cytolysis and induction of Fas–Fas ligand-
mediated apoptosis in target cells. Thus, it is tempting to
hypothesize that in the inflammatory setting in which
cross-reactive T cell clones are activated, parietal cells may
express APC functions, becoming target, at the same time,
of the cytotoxic and proapoptotic activity of cross-reactive
gastric T cells. The end point of this process would be gas-
tric corpus atrophy and hypochloridria.
One may ask whether the T cells which cross-react with
H. pylori antigens are simply a chance finding and what is
the probability of any T cell response showing some cross-
reactivity with the total protein mixture from H. pylori.
Based on the reported degeneracy of both TCR and MHC
binding (29, 30), there is indeed a theoretical chance of
such coincidental cross-reactivity. However, such a pro-
miscuity of T cell responses to H. pylori lysate could not be
found in a series of 206 CD4 human T cell clones isolated
from atherosclerotic plaques, which included 46 clones that
recognized Chlamydia pneumoniae antigens (31), although
Table III. Effect of Addition in Culture of Anti-DR or Anti-DQ Monoclonal Antibodies on the Proliferative Response to Self 
and Cross-reactive Peptides by Gastric T Cell Clones Reactive to both H,K-ATPase and H. pylori Lysate
T cell
clones
Proliferative responsea in the presence of:
Peptide added in culture Isotype control Anti-DR Anti-DQ
1.C31 H,K-ATPase 621-635 110 	 7 1.6 	 0.1 115 	 9
Histidine kinase, 264-278 101 	 5 1.5 	 0.1 100 	 7
1.A04 H,K-ATPase 781-795 173 	 10 1.1 	 0.1 160 	 8
Dimethyl adenosine transferase, 99-113 148 	 11 1.0 	 0.1  151 	 10
2.P24 H,K-ATPase 46-60 31 	 2 1.2 	 0.1 30 	 3
Penicillin-binding protein 2, 104-118 38 	 2 0.9 	 0.1 38 	 3
2.R37 H,K-ATPase 836-850 61 	 4 1.1 	 0.1 58 	 5
LPS biosynthesis protein, 11-25 32 	 3 1.2 	 0.1 35 	 4
3.A30 H,K-ATPase 836-850 42 	 4 1.0 	 0.1 40 	 5
LPS biosynthesis protein, 11-25 22 	 2 1.3 	 0.1 23 	 1
4.A15 H,K-ATPase 181-195 48 	 3 1.4 	 0.1 49 	 4
Acetate kinase, 93-107 29 	 2 1.0 	 0.1 30 	 2
4.C32 H,K-ATPase 241-255 98 	 9 1.1 	 0.1 96 	 8
Phosphoglucosamine mutase, 70-84 89 	 9 1.2 	 0.1 90 	 10
4.C27 H,K-ATPase 256-270 118 	 10 1.9 	 0.2 106 	 11
VirB4 homologue, 78-92 59 	 4 0.9 	 0.1 58 	 5
4.C26 H,K-ATPase 516-530 127 	 9 1.4 	 0.1 126 	 10
GidA, 571-585 56 	 6 1.3 	 0.1 55 	 7
4.A05 H,K-ATPase 621-635 97 	 9 1.0 	 0.1 96 	 8
Porphobilinogen deaminase, 35-49 60 	 6 1.1 	 0.1 62 	 5
aValues are MI 	 SD.
GidA, glucose-inhibited division protein A.
T
h
e 
Jo
u
rn
al
 o
f 
E
xp
er
im
en
ta
l 
M
ed
ic
in
e
Molecular Mimicry between H,K-ATPase and H. pylori Antigens1154
one might expect more similarity between the proteomes
of both bacteria than between the human proteome and
that of H. pylori.
T cell recognition of a peptide depends on anchor resi-
dues involved in binding to the MHC molecule as well as
on TCR contact residues. This suggests that the self pep-
tide and the bacterial peptide recognized by a single T
cell, should be considerably homologous in amino acid se-
quence. However, degeneracy in both TCR (32) and
MHC binding–motives (33) reduces this sequence-spe-
cific requirement to only a few crucial residues, and it has
been demonstrated that in the animal model of myocardi-
tis cross-recognition of the autoantigen (myosin) and the
microbial peptide (Chlamydia cysteine-rich outer mem-
brane protein) depends on only four identical residues in
the 16 amino acid epitope sequence (34). Another mecha-
nism of TCR cross-recognition may work. Recently,
MHC-based molecular mimicry has been reported to un-
derlie TCR cross-reactivity in multiple sclerosis (35). A T
cell clone from a patient recognizes both myelin basic
protein amino acids 85–99 and Epstein-Barr virus (EBV)
DNA polymerase peptide EBV627-641, but recognition
of these peptides is restricted by two different DR2 mole-
cules (i.e., DRB1*1501 and DRB5*0101, respectively).
Crystal structure determination revealed structural similar-
ities of both DR–peptide complexes at the surface pre-
sented for TCR recognition, thus explaining the mecha-
nism that may underlie the mimicry between EBV and
myelin basic protein.
Blocking experiments with anti-DR and anti-DQ anti-
bodies showed that DR represents the MHC restriction el-
ement. However, because all our patients are heterozygous
for DR alleles, we cannot exclude that the aforementioned
mechanism of TCR cross-reactivity is responsible for the
mimicry between H. pylori and H,K-ATPase observed
here.
None of the bacterial epitopes recognized by the cross-
reactive T cell clones in the present paper belong to H. py-
lori immunodominant proteins (i.e., CagA, VacA, and ure-
ase), which have been identified previously as targets of the
majority of gastric T cells in H. pylori–infected patients
with chronic antral gastritis (28) and peptic ulcer (26). It re-
mains unknown to what extent the H. pylori epitopes rec-
ognized by the cross-reactive T cells described here are rel-
evant to bacterial infection.
A clear example of epitope mimicry in humans is Lyme
arthritis, in which Borrelia burgdorferi disseminates to multi-
ple tissues, including joints. In the synovia of patients with
specific MHC class II haplotypes, activation of Th1 cells
reactive to the 165–173 peptide of the outer surface protein
A of B. burgdorferi occurs (29, 30). Such an epitope is similar
to the L332–340 peptide of the human leukocyte function-
associated antigen 1, whose expression is up-regulated on
synoviocytes by the Th1-derived IFN- (36–38). How-
ever, some aspects of this model of human molecular mim-
icry are questioned because it is still unknown what pre-
cipitates the disease several months after the borrelial
infection, whether the human leukocyte function-associ-
ated antigen 1 epitopes are actually being presented in the
joints, and what kind of APCs would be involved (5).
With regard to the question of whether it was H. pylori
infection or H. pylori–independent gastric autoimmunity
that initiated disease, three hypotheses can be suggested.
First, our patients, having inherited MHC haplotypes that
predispose to organ-specific autoimmunity (39), already
had undiagnosed or subclinical AIG and H. pylori infec-
tion, by providing a number of epitopes cross-reactive
to H,K-ATPase, caused a Th1-mediated inflammation
leading to the expansion of both cross-reactive and single
(H,K-ATPase)-reactive gastric T cells. The outcome
was increased parietal cell destruction and gastric atrophy.
Second, H. pylori was the initiating factor, and primary ac-
tivation of gastric Th1 cells reactive to H. pylori peptides
that cross-react with H,K-ATPase resulted in an inflam-
matory process in which T cell–derived IFN- allowed
H,K-ATPase-bearing parietal cells to act as APCs and to
become targets of cross-reactive epitope recognition and
killing and/or apoptotic suicide. Apoptotic parietal cells
would allow cross-priming of T cells specific for private
H,K-ATPase epitopes, ultimately leading to full blown
AIG by epitope spreading. Third, H. pylori infection was an
epiphenomenon, playing no role in the natural history of
the disease.
Our data fulfil most of the criteria proposed for assessing
a case of molecular mimicry (1, 5, 12). In our patients,
there was a temporal association between clinical and sero-
logical evidence of AIG and H. pylori infection, at least at
the time of culture of their in vivo–activated gastric T cells.
Because H. pylori is commonly acquired in young life (19),
the infection preceded symptoms of AIG that usually arise
later in life. Taking into account the wide diffusion of H.
pylori (19), one may suspect that some AIG patients, who
were found H. pylori–negative at the time of their diagnosis
of AIG, might have harbored the bacterium previously,
and H. pylori was lost while mucosal atrophy was ongoing.
Strikingly, all our AIG patients lost H. pylori during the
4-yr study period, possibly due to hypochloridria that made
their gastric environment no more appreciated by the bac-
terium. The possibility that H. pylori gets lost due to in-
creasing gastric atrophy and hypochloridria has already
been reported (40).
We have identified a quite broad repertoire of culprit
epitopes in both the pathogen and in the self gastric protein
associated with AIG. The microbial cross-reactive epitopes
were able to elicit vigorous responses in the same gastric T
cells that responded at comparable levels to both the corre-
sponding self H,K-ATPase epitopes and the entire self
protein. Finally, cross-reactive T cell clones quantitatively
represented a significant component of the T cell response
at gastric level during the autoimmune disease and the con-
comitant H. pylori infection. This would argue against the
possibility that the detection at gastric level of autoreactive,
cytotoxic, and proapoptotic Th1 cells that cross-react to H.
pylori epitopes is simply an epiphenomenon.
Together, our results support the idea that in genetically
susceptible individuals, H. pylori infection triggers or accel-
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erates the development of gastric autoimmunity via molec-
ular mimicry.
This work was supported by grants from the Italian Ministry of
University and Research, the Ministry of Health (Istituto Superiore
di Sanità), and the Associazione Italiana per la Ricerca sul Cancro.
Submitted: 2 April 2003
Revised: 22 August 2003
Accepted: 2 September 2003
References
1. Rose, N.R., and C. Bona. 1993. Defining criteria for au-
toimmune diseases (Witebsky’s postulates revisited). Immunol.
Today. 14:426–430.
2. Oldstone, M.B.A. 1998. Molecular mimicry and immune-
mediated diseases. FASEB J. 12:1255–1265.
3. Theofilopoulos, A.N., and D.H. Kono. 1998. Mechanisms
and genetics of autoimmunity. Ann. NY Acad. Sci. 841:225–
235.
4. Lori, J.A., and R.D. Inman. 1999. Molecular mimicry and
autoimmunity. N. Engl. J. Med. 341:2068–2074.
5. Benoist, C., and D. Mathis. 2001. Autoimmunity provoked
by infection: how good is the case for T cell epitope mim-
icry? Nat. Immunol. 2:797–801.
6. Wucherpfennig, K.W. 2001. Mechanisms for the induction
of autoimmunity by infectious agents. J. Clin. Invest. 108:
1097–1104.
7. Schrer, M.T., L. Ignatowicz, G.M. Winslow, J.W. Kappler,
and P. Marrack. 1993. Superantigens: bacterial and viral pro-
teins that manipulate the immune system. Annu. Rev. Cell
Biol. 9:101–128.
8. Lehmann, P.V., T. Forsthuber, A. Miller, and E.E. Sercarz.
1992. Spreading of T-cell autoimmunity to cryptic determi-
nants of an autoantigen. Nature. 358:155–157.
9. Miller, S.D., C.L. Vanderlugt, W.S. Begolka, W. Pao, R.L.
Yauch, K.L. Neville, Y. Katz-Levy, A. Carrizosa, and B.S.
Kim. 1997. Persistent infection with Theiler’s virus leads
to CNS autoimmunity via epitope spreading. Nat. Med.
3:1133–1136.
10. Murali-Krishna, K., J.D. Altman, M. Suresh, D.J. Sourdive,
A.J. Zajac, J.D. Miller, J. Slansky, and R. Ahmed. 1998.
Counting antigen-specific CD8 T cells: a reevaluation of by-
stander activation during viral infection. Immunity. 8:177–
187.
11. Bachmaier, K., N. Neu, L.M. de la Maza, S. Pal, A. Hessel,
and J.M. Penninger. 1999. Chlamydia infections and heart
disease linked through antigenic mimicry. Science. 283:1335–
1339.
12. Rose, N.R., and I.R. Mackay. 2000. Molecular mimicry: a
critical look at exemplary instances in human diseases. Cell.
Mol. Life Sci. 57:542–551.
13. Hemmer, B., B. Gran, Y. Zhao, A. Marques, J. Pascal, A.
Tzou, T. Kondo, I. Cortese, B. Bielekova, S.E. Straus, et al.
1999. Identification of candidate T-cell epitopes and molecu-
lar mimics in chronic Lyme disease. Nat. Med. 5:1375–1382.
14. Martin, R., B. Gran, Y. Zhao, S. Markovic-Plese, B. Biele-
kova, A. Marques, M.H. Sung, B. Hemmer, R. Simon, H.F.
McFarland, and C. Pinilla. 2001. Molecular mimicry and
antigen-specific T cell responses in multiple sclerosis and
chronic CNS Lyme disease. J. Autoimmun. 16:187–192.
15. Toh, B.H., I.R. van Driel, and P.A. Gleeson. 1997. Perni-
cious anemia. N. Engl. J. Med. 337:1441–1448.
16. Karlsson, F.A., P. Burman, L. Loof, and S. Mardh. 1988. Ma-
jor parietal cell antigen in autoimmune gastritis with perni-
cious anemia is the acid-producing H,K-adenosine tri-
phosphatase of the stomach. J. Clin. Invest. 81:475–479.
17. Toh, B.H., I.R. van Driel, and P.A. Gleeson. 1992. Autoim-
mune gastritis: tolerance and autoimmunity to the gastric
H/K ATPase (proton pump). Autoimmunity. 13:165–172.
18. D’Elios, M.M., M.P. Bergman, A. Azzurri, A. Amedei, M.
Benagiano, J.J. De Pont, F. Cianchi, C.M. Vandenbroucke-
Grauls, S. Romagnani, B.J. Appelmelk, and G. Del Prete.
2001. H(),K()-ATPase (proton pump) is the target au-
toantigen of Th1-type cytotoxic T cells in autoimmune gas-
tritis. Gastroenterology. 120:377–386.
19. Suerbaum, S., and P. Michetti. 2002. Helicobacter pylori infec-
tion. N. Engl. J. Med. 347:1175–1186.
20. Appelmelk, B.J., G. Faller, D. Claeys, T. Kirchner, and
C.M.J.E. Vandenbroucke-Grauls. 1998. Bugs on trial: the
case of Helicobacter pylori and autoimmunity. Immunol. To-
day. 19:296–299.
21. Faller, G., M. Winter, H. Steininger, N. Lehn, A. Meining,
E. Bayerdorffer, and T. Kirchner. 1999. Decrease of antigas-
tric autoantibodies in Helicobacter pylori gastritis after cure of
infection. Pathol. Res. Pract. 195:243–246.
22. Swarts, H.G., T.J. Van Uem, S. Hoving, J.A. Fransen, and
J.J. De Pont. 1991. Effect of free fatty acids and detergents on
H,K-ATPase. The steady-state ATP phosphorylation level
and the orientation of the enzyme in membrane preparations.
Biochim. Biophys. Acta. 1070:283–292.
23. Maeda, M., J. Ishizaki, and M. Futai. 1988. cDNA cloning
and sequence determination of pig gastric (H,K)-ATPase.
Biochem. Biophys. Res. Commun. 157:203–206.
24. Van der Zee, R., S.M. Anderton, C.A.F. Buskens, E. Alonso
de Velasco, and W. Van Eden. 1995. Heat shock protein T
cell epitopes as immunogenic carriers in subunit vaccines. In
Peptides 1994, Proceedings of the Twenty-Third Peptide
Symposium. H.L.S. Maya, editor. ESCOM, Leiden, Nether-
lands. 842.
25. Sing, H., and G.P.S. Raghava. 2001. ProPred: prediction of
HLA-DR binding sites. Bioinformatics. 17:1236–1237.
26. D’Elios, M.M., M. Manghetti, M. De Carli, F. Costa, C.T.
Baldari, D. Burroni, J.L. Telford, S. Romagnani, and G. Del
Prete. 1997. Th1 effector cells specific for Helicobacter pylori in
the gastric antrum of patients with peptic ulcer disease. J. Im-
munol. 158:962–967.
27. Vergelli, M., B. Hemmer, P.A. Muraro, L. Tranquill, W.E.
Biddison, A. Sarin, H.F. McFarland, and R. Martin. 1997.
Human autoreactive CD4 T cell clones use perforin or Fas/
Fas ligand-mediated pathways for target cell lysis. J. Immunol.
158:2756–2761.
28. D’Elios, M.M., M. Manghetti, F. Almerigogna, A. Amedei,
F. Costa, D. Burroni, C.T. Baldari, S. Romagnani, J.L. Tel-
ford, and G. Del Prete. 1997. Different cytokine profile and
antigen-specificity repertoire in Helicobacter pylori-specific T
cell clones from the antrum of chronic gastritis patients with
or without peptic ulcer. Eur. J. Immunol. 27:1751–1755.
29. Kersh, G.J., and P.M. Allen. 1996. Structural basis for T cell
recognition of altered peptide ligands: a single T cell receptor
can productively recognize a large continuum of related
ligands. J. Exp. Med. 184:1259–1268.
30. Hemmer, B., M. Vergelli, C. Pinilla, R. Houghten, and R.
Martin. 1998. Probing degeneracy in T-cell recognition us-
ing combinatorial peptide libraries. Immunol. Today. 19:163–
T
h
e 
Jo
u
rn
al
 o
f 
E
xp
er
im
en
ta
l 
M
ed
ic
in
e
Molecular Mimicry between H,K-ATPase and H. pylori Antigens1156
168.
31. Benagiano, M., A. Azzurri, A. Ciervo, A. Amedei, C. Tam-
burini, M. Ferrari, J.L. Telford, C.T. Baldari, S. Romagnani,
A. Cassone, et al. 2003. T helper type 1 lymphocytes drive
inflammation in human atherosclerotic lesions. Proc. Natl.
Acad. Sci. USA. 100:6658–6663.
32. Wucherpfennig, K.W., D.A. Hafler, and J.L. Strominger.
1995. Structure of human T-cell receptors specific for an im-
munodominant myelin basic protein peptide: positioning of
T-cell receptors on HLA-DR2/peptide complexes. Proc.
Natl. Acad. Sci. USA. 92:8896–8900.
33. Wucherpfennig, K.W., A. Sette, S. Southwood, C. Oseroff,
M. Matsui, J.L. Strominger, and D.A. Hafler. 1994. Struc-
tural requirements for binding of an immunodominant my-
elin basic protein peptide to DR2 isotypes and for its recog-
nition by human T cell clones. J. Exp. Med. 179:279–290.
34. Bachmaier, K., N. Neu, L.M. de la Maza, S. Pal, A. Hessel, and
J.M. Penninger. 1999. Chlamydia infections and heart disease
linked through antigenic mimicry. Science. 283:1335–1339.
35. Lang, H.L., H. Jacobsen, S. Ikemizu, C. Andersson, K. Har-
los, L. Madsen, P. Hjorth, L. Sondergaard, A. Svejgaard, K.
Wucherpfennig, et al. 2002. A functional and structural basis
for TCR cross-reactivity in multiple sclerosis. Nat. Immunol.
3:940–943.
36. Lengl-Janssen, B., A.F. Strauss, A.C. Steere, and T. Kamradt.
1994. The T helper cell response in Lyme arthritis: differen-
tial recognition of Borrelia burgdorferi outer surface protein A
in patients with treatment-resistant or treatment-responsive
Lyme arthritis. J. Exp. Med. 180:2069–2078.
37. Gross, D.M., T. Forsthuber, M. Tary-Lehmann, C. Etling,
K. Ito, Z.A. Nagy, J.A. Field, A.C. Steere, and B.T. Huber.
1998. Identification of LFA-1 as a candidate autoantigen in
treatment-resistant Lyme arthritis. Science. 281:703–706.
38. Akin, E., J. Aversa, and A.C. Steere. 2001. Expression of ad-
hesion molecules in synovia of patients with treatment-resis-
tant Lyme arthritis. Infect. Immun. 69:1774–1780.
39. McDevitt, H.O. 2000. Discovering the role of the major his-
tocompatibility complex in the immune response. Annu. Rev.
Immunol. 18:1–17.
40. Ma, J.-Y., K. Borch, S.E. Sjöstrand, L. Janzon, and S. Mårdh.
1994. Positive correlation between H,K-adenosine triphos-
phatase autoantibodies and Helicobacter pylori antibodies in pa-
tients with pernicious anemia. Scand. J. Gastroenterol. 29:961–
965.
